Related Experiment Videos
[Acrodermatitis enteropathica in childhood (author's transl)]
Klinische Padiatrie
|November 1, 1977
Insights
A five-month-old infant with acrodermatitis enteropathica (AE) highlights the disease's causes and progression. Zinc substitution is presented as a superior alternative to oxychinolin therapy due to fewer side effects.
Area of Science:
- Pediatric Dermatology
- Nutritional Science
- Gastroenterology
Context:
- A five-month-old infant presented with symptoms indicative of acrodermatitis enteropathica (AE).
- The case report details the etiological factors and pathogenesis of AE.
- The clinical course of the disease in this infant is thoroughly documented.
Purpose:
- To describe the etiology, pathogenesis, and clinical presentation of acrodermatitis enteropathica in an infant.
- To evaluate the side effects associated with oxychinolin therapy for AE.
- To demonstrate the advantages and benefits of zinc supplementation as a treatment for AE.
Summary:
- The study details a case of acrodermatitis enteropathica (AE) in a five-month-old infant, outlining its causes and disease progression.
- Oxychinolin therapy was administered, but its associated side effects were noted.
- Substitution with zinc proved to be a more beneficial and safer therapeutic approach, highlighting zinc's crucial role in AE management.
Impact:
- This case underscores the importance of early diagnosis and appropriate management of acrodermatitis enteropathica.
- It provides evidence for the efficacy and safety of zinc supplementation in treating AE, potentially improving patient outcomes.
- The findings contribute to understanding the therapeutic landscape for inborn errors of zinc metabolism.
Abstract:
A five months old infant is described with acrodermatitis enteropathica. The aetiology, pathogenesis and the clinical course of the disease is reported. It will be discussed the side effects of the oxychinolin therapy, the advantages and benefits of the substitution with zinc.